Cargando…
Venetoclax plus hypomethylating agents or low-dose cytarabine in acute myeloid leukemia: all that glitters is gold?
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6987123/ https://www.ncbi.nlm.nih.gov/pubmed/31992691 http://dx.doi.org/10.1038/s41408-020-0281-x |
_version_ | 1783492080836804608 |
---|---|
author | Ferrara, Felicetto |
author_facet | Ferrara, Felicetto |
author_sort | Ferrara, Felicetto |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-6987123 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-69871232020-02-05 Venetoclax plus hypomethylating agents or low-dose cytarabine in acute myeloid leukemia: all that glitters is gold? Ferrara, Felicetto Blood Cancer J Correspondence Nature Publishing Group UK 2020-01-28 /pmc/articles/PMC6987123/ /pubmed/31992691 http://dx.doi.org/10.1038/s41408-020-0281-x Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Correspondence Ferrara, Felicetto Venetoclax plus hypomethylating agents or low-dose cytarabine in acute myeloid leukemia: all that glitters is gold? |
title | Venetoclax plus hypomethylating agents or low-dose cytarabine in acute myeloid leukemia: all that glitters is gold? |
title_full | Venetoclax plus hypomethylating agents or low-dose cytarabine in acute myeloid leukemia: all that glitters is gold? |
title_fullStr | Venetoclax plus hypomethylating agents or low-dose cytarabine in acute myeloid leukemia: all that glitters is gold? |
title_full_unstemmed | Venetoclax plus hypomethylating agents or low-dose cytarabine in acute myeloid leukemia: all that glitters is gold? |
title_short | Venetoclax plus hypomethylating agents or low-dose cytarabine in acute myeloid leukemia: all that glitters is gold? |
title_sort | venetoclax plus hypomethylating agents or low-dose cytarabine in acute myeloid leukemia: all that glitters is gold? |
topic | Correspondence |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6987123/ https://www.ncbi.nlm.nih.gov/pubmed/31992691 http://dx.doi.org/10.1038/s41408-020-0281-x |
work_keys_str_mv | AT ferrarafelicetto venetoclaxplushypomethylatingagentsorlowdosecytarabineinacutemyeloidleukemiaallthatglittersisgold |